Login to Your Account

Biotie Beefs up CNS Pipe with $120M Synosia Buy

By Nuala Moran

Wednesday, January 12, 2011
LONDON – Biotie Therapies Corp. is acquiring Synosia Therapeutics Holding AG in an all-share deal that values the private Swiss company at €93.6 million (US$120.95 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription